Not every DRG denial is the same fight. A payer that reassigns a code because the documentation doesn’t support the diagnosis as billed is making a different argument than a payer that accepts the documentation but disputes whether the diagnosis was clinically valid in the first place. Treat them the same way and hospitals lose ground on both.
A January 27, 2026 client alert from law firm Davis Wright Tremaine put a sharp point on the distinction: coding-based downgrades turn on documentation and coding guidelines, while clinical validation denials challenge the physician’s clinical basis for a diagnosis independent of how it was coded. The firm’s advice was blunt — “match the strategy to the denial: use coding expertise for coding-based downgrades and reserve clinician reviews for cases that challenge the diagnosis itself.” Hospitals that route every denial through the same queue are, by definition, misrouting half of them.
Two denial types, two different arguments
The mechanics matter because the two categories require different evidence and different reviewers. A coding downgrade is won or lost on ICD-10-CM guidelines, Coding Clinic advice, and documentation completeness — a coder’s or CDI specialist’s territory. A clinical validation denial is won or lost on whether the clinical picture — vitals, labs, treatment, physician judgment — actually supports the diagnosis, which requires a physician reviewer who can argue clinical merit, not code assignment.
Sending a clinical validation denial to a coding team, or a coding downgrade to a physician advisor, wastes the appeal window and usually produces the wrong argument entirely. A coder asked to defend a clinical validation denial will, understandably, respond with a coding citation — correct code, correct guideline, correct sequencing — none of which answers the payer’s actual objection. The appeal gets denied a second time, now with less runway left before the deadline expires.
Where the risk concentrates
According to the same DWT analysis, four DRG families draw a disproportionate share of clinical validation scrutiny from payors:
- Sepsis (DRGs 871–873)
- Acute kidney injury / renal failure (DRGs 682–684)
- Malnutrition and nutritional disorders (DRGs 951–953)
- Encephalopathy and stroke-related conditions (DRGs 064–066)
These aren’t obscure edge cases — they’re high-volume, high-acuity diagnoses where the clinical criteria (sepsis definitions, staging for AKI, malnutrition assessment tools) leave genuine room for disagreement even when the documentation is complete. That ambiguity is exactly what payors are testing.
Why routing breaks down at scale
The coder’s blind spot
Coders are trained to defend code assignment against the record as written. When a denial actually disputes the clinical validity of a physician’s diagnosis, no amount of coding-guideline citation moves the payer — the argument was never about the code.
The physician advisor’s bottleneck
Physician advisors are a limited, expensive resource. Routing straightforward coding downgrades to them for review burns capacity that should be reserved for the DRGs above, where a clinician’s judgment is the only argument that counts.
DWT’s recommended fix — analyzing prior-year denial trends by type and DRG, and tracking payor-specific appeal deadlines that the firm notes can range from 30 days to a full year — assumes hospitals can first classify a denial correctly and fast enough to act. That classification step is where the bottleneck usually sits.
Where agentic AI actually helps
This is a routing and triage problem before it’s an appeals-writing problem, and it’s a reasonable target for agentic AI rather than a fully automated black box. An agent can read an incoming denial letter, classify it as a coding-based downgrade or a clinical validation dispute based on the payer’s stated rationale, pull the relevant chart sections and prior Coding Clinic guidance for that DRG, and route the case to the coding team or the physician advisor queue accordingly — with the appeal-deadline clock attached so nothing ages out of the window DWT flagged.
None of that requires the AI to win the argument on its own. It requires the AI to get the case to the right human, with the right supporting material, before the deadline — which is a narrower and more defensible claim than “AI writes your appeal,” and one that’s easier to audit when a compliance team asks how a denial was handled. That auditability matters for a second reason: payors are actively watching how AI shows up in provider workflows, and a hospital that can point to a documented, human-reviewed routing decision is in a materially better position than one that can’t explain why a denial went to the queue it did.
Pre-bill is the cheaper fight
The same classification logic works upstream of billing, not just at the appeal stage. Flagging a sepsis, AKI, malnutrition, or encephalopathy chart for clinical-validation risk before the claim goes out — rather than after a payer denies it — turns an appeal into a documentation query, which is a faster and cheaper problem to solve. Hospitals that build this pre-bill check into their CDI workflow are, in effect, betting fewer claims into DRGs 871–873, 682–684, 951–953, and 064–066 without first confirming the clinical criteria are met and clearly documented.
Medikode’s automated medical coding platform applies this kind of triage logic to coding and CDI workflows directly, helping teams separate coding-accuracy questions from clinical-validity questions before either one turns into a missed appeal deadline.